Pentax announces availability of pediatric-sized colonoscope in Canada

4 February 2013 (Last Updated February 4th, 2013 18:30)

Health Canada has granted license to Pentax Medical's paediatric size (11.6mm) colonoscope for use in diagnostic colonoscopy procedures for colorectal cancer screening and therapeutic colonoscopy procedures such as endoscopic polypectomy.

Health Canada has granted license to Pentax Medical's paediatric size (11.6mm) colonoscope for use in diagnostic colonoscopy procedures for colorectal cancer screening and therapeutic colonoscopy procedures such as endoscopic polypectomy.

The Pentax RetroView Colonoscope (EC-3490TLi), which the company claims is the first high-definition video colonoscope with an enhanced retroflex bending section, features a 210° tip angulation and shorter bending section (9.0cm length) that reduces the retroflex position diameter by 25%, when compared to the company's EC-3490Li paediatric colonoscope.

Compatible with the Pentax HD+ line of processors, EC-3490TLi also features Pentax HD+ image quality, 3.2mm instrument channel, four-way tip angulation and forward viewing and 140° field-of-view optics.

"EC-3490TLi offers greater manoeuvrability, which provides the potential for visualisation of more hidden polyps and easier access to the distal side of polyps."

EC-3490TLi offers greater manoeuvrability, which provides the potential for visualisation of more hidden polyps and easier access to the distal side of polyps, according to the endoscopic products company.

Pentax Medical president David Woods said that the launch of the new colonoscope forms part of the company's strategy of becoming a trusted partner with the gastrointestinal endoscopy community.

"We continue to strengthen this partnership by delivering the best endoscopic products and creating cost-effective solutions," Woods added.

"We are excited about this product's potential impact on advancing both meaningful clinical care and hospital efficiency."

The company said the paediatric-sized colonoscope, which is available in select European and Asian markets, will soon be launched in the US and Latin America.